Powerful solar telescope unveils ultra-fine magnetic 'curtains' on the sun's surface
When you buy through links on our articles, Future and its syndication partners may earn a commission.
The National Science Foundation's (NSF) Daniel K. Inouye Solar Telescope, located on the summit of Haleakalā on the island of Maui, Hawaii, captured the sharpest-ever images of the sun's surface.
The images show ultra-fine bright and dark stripes (called striations) in the thin, gaseous layer of the sun's atmosphere known as the photosphere, according to a statement from the National Solar Observatory (NSO), which operates the solar telescope.
"In this work, we investigate the fine-scale structure of the solar surface for the first time with an unprecedented spatial resolution of just about 20 kilometers [12.4 miles], or the length of Manhattan Island," David Kuridze, lead author of the study and a NSO scientists, said in the statement. "These striations are the fingerprints of fine-scale magnetic field variations."
The striations appear as alternating bright and dark stripes along the walls of solar granules — the convection cells that transport heat from the sun's interior to its surface. These patterns result from curtain-like magnetic fields that ripple and shift like fabric fluttering in the wind.
As light from the hot granule walls passes through these magnetic "curtains," variations in the magnetic field strength cause changes in brightness, effectively tracing the underlying magnetic structures. If the magnetic field is weaker than in its surroundings, it appears darker; if stronger, it glows brighter.
Therefore, the striations are believed to be signatures of subtle yet powerful magnetic fluctuations, which alter the density and opacity of the solar plasma. These slight shifts are only detectable thanks to the telescope's Visible Broadband Imager (VBI), which operates in the G-band — a specific range of visible light that highlights areas with strong magnetic activity.
Related Stories:
— The sun's magnetic field will flip soon. Here's what to expect
— How the Sun's Magnetic Field Works
— Magnetic fields appear to be as old as the universe itself. What created them?
Unraveling the sun's magnetic architecture is key to understanding phenomena like solar flares, eruptions and coronal mass ejections (CMEs), which drive space weather and can impact Earth.
The team's findings were published May 20 in The Astrophysical Journal Letters.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
a day ago
- CBS News
Trump administration's National Science Foundation research funding cuts blocked by judge
A federal judge has blocked President Trump's administration from making drastic cuts to research funding provided by the National Science Foundation. U.S. District Judge Indira Talwani in Boston struck down on Friday a policy change that could have stripped universities of tens of millions of dollars in research funding. The universities argued the move threatened critical work in artificial intelligence, cybersecurity, semiconductors and other technology fields. Talwani said the change, announced by the NSF in May, was arbitrary and capricious and contrary to law. An email by the Associated Press on Saturday to the NSF was not immediately returned. At issue are "indirect" costs, expenses such as building maintenance and computer systems that aren't linked directly to a specific project. Currently, the NSF determines each grant recipient's indirect costs individually and is supposed to cover actual expenses. The Trump administration has dismissed indirect expenses as "overhead" and capped them for future awards by the NSF to universities at 15 % of the funding for direct research costs. The University of California, one of the plaintiffs, estimated the change would cost it just under $100 million a year. Judges have blocked similar caps that the Trump administration placed on grants by the Energy Department and the National Institutes of Health. In a recent interview on "CBS Mornings Plus," Todd Wolfson, president of the American Association of University Professors — whose organization sued the Trump administration over federal funding cuts to Columbia University — said examples of research that has been cut includes a research project that looks at discerning when AI is making fake videos or a project that examines when people start to believe lies that are repeatedly told. "We are losing all the critical research that helps us understand truth and fiction in our social media platforms, whether it's Facebook or X or any other platform," he said.
Yahoo
2 days ago
- Yahoo
US judge blocks slashing of universities' federal funding from National Science Foundation
By Nate Raymond and Blake Brittain (Reuters) -A federal judge on Friday prevented the National Science Foundation from sharply cutting research funding provided to universities in the latest legal setback to efforts by U.S. President Donald Trump's administration to slash government support of research at major academic institutions. U.S. District Judge Indira Talwani in Boston invalidated a policy NSF adopted in May that limited the ability of universities to be reimbursed for administrative and facility costs that indirectly support grant-funded research, ruling that it was "arbitrary and capricious." Spokespeople for NSF and the White House did not immediately respond to requests for comment on the ruling. NSF, a $9 billion agency that funds scientific research, adopted the policy after having already canceled hundreds of grants out of step with the Republican president's priorities. His administration has also been freezing billions of dollars in government funding for numerous universities, including Harvard. NSF's policy, which was announced on May 2, set a cap on how much grant funding could go to cover indirect costs. NSF said funding for such costs could equal no more than 15% of the funding for direct research costs, regardless of what the costs actually were at universities. Historically, universities had negotiated with NSF and other agencies over the rate at which indirect costs could be reimbursed. The cap meant that for every $100 in funding going directly to a research grant award, universities would receive just $15 to cover overhead, such as the costs of maintaining lab space and paying for electricity and staff. The Trump administration said it sought through the policy to rein in spending on administrative overhead, which had grown to consume $1.07 billion of NSF's annual $4.22 billion grant-making budget for higher education institutions. That rate, though, is significantly lower than the indirect cost that many of the 69 research universities belonging to Association of American Universities had negotiated, which was often in the 50% to 65% range, the group's lawyers said. Talwani, an appointee of Democratic President Barack Obama, said in her Friday decision that the administration's 15% rate was unlawful. The association along with two other academic trade groups and 13 schools sued in May to block the policy, after earlier convincing judges in Boston to block similar funding cuts at the National Institutes of Health and U.S. Department of Energy. The association did not immediately respond to a request for comment on the Friday decision. Among the schools that challenged NSF's funding cuts were the Massachusetts Institute of Technology, Princeton University, Brown University, the University of California, Carnegie Mellon University, Cornell University, the University of Michigan and the University of Pennsylvania. They argued that NSF's action, if allowed to stand, "will badly undermine scientific research at America's universities and erode our nation's enviable status as a global leader in scientific research and innovation." The U.S. Department of Defense has since also adopted a 15% cap, which a judge on Tuesday temporarily blocked pending a hearing on July 2. He did so a day after a different judge in Boston ordered NIH to reinstate hundreds of grants for research on diversity-related topics nixed as part of the administration's purge of initiatives viewed as supporting "diversity, equity and inclusion."
Yahoo
2 days ago
- Yahoo
Just 1 dose of magic mushroom compound eases depression for at least 5 years in most patients, small study suggests
When you buy through links on our articles, Future and its syndication partners may earn a commission. DENVER—Psilocybin, the main psychoactive ingredient in magic mushrooms, can alleviate depression for at least five years after a single dose, a new study finds. The research, presented June 18 at the Psychedelic Science 2025 conference in Denver, focused on patients with major depressive disorder (MDD), which is often called clinical depression. The serious mood disorder causes a persistent feeling of sadness and a loss of interest or pleasure in activities that were once enjoyable. The most common treatments for MDD include talk therapy and medications such as selective serotonin reuptake inhibitors, and both can take a long time to show any benefits. When early studies hinted at psilocybin's potential as an antidepressant, a team of researchers undertook the first-ever randomized clinical trial to explore the use of the psychedelic for treating severe depression. The trial included 24 patients, half of whom received psilocybin at the very start of the trial and half of whom received the same dose eight weeks later—the "waitlist" group. Each patient also received 11 hours of psychotherapy. Even in that short time frame, "there was a significant reduction in depression in the immediate-treatment group compared to those on the waitlist," study co-author Alan Davis, director of the Center for Psychedelic Drug Research and Education at The Ohio State University, told Live Science. Once all of the patients had completed the four-week study, the psilocybin appeared to be four times more effective than traditional antidepressant medications, based on previous research data. One month after the treatment, 17 patients had relieved symptoms, including 14 who were in full remission from depression. Patients also responded much faster to psilocybin than is typical for conventional antidepressants. But do these benefits of psilocybin last? Related: Magic mushrooms temporarily 'dissolve' brain network responsible for sense of self Very few long-term studies of psilocybin for depression have been conducted to date, said Dr. Charles Raison, a professor of human ecology and psychiatry at the University of Wisconsin-Madison who was not involved in the research. "They are very difficult to do because people drop out," Raison told Live Science in an email. "But also because they go on all sorts of other treatments that obfuscate the degree to which any longer lasting benefits result from the psychedelic or because the participant got therapy or restarted an antidepressant." To investigate whether the benefits for psilocybin lasted and if the patients had experienced any side effects, the researchers contacted the original trial participants several years later to request their enrollment in a follow-up study. Twenty-one patients enrolled, and their clinicians rated any changes in the participants' levels of depression from before the original treatment to the present day. The patients also filled out a series of self-reported, online questionnaires and met up with clinicians to document their ability to engage in everyday tasks, their levels of anxiety and their general mental health. The researchers assumed that the three patients that didn't sign up for the follow up, and the three that didn't complete the questionnaires had not remained in remission. Even so, the researchers found that 67% of the participants who had suffered from depression half a decade earlier remained in remission after a single psychedelic therapy session. These patients also reported less anxiety and less difficulty functioning on a daily basis. In general, the two-thirds of the patients who responded well reported lasting positive changes in their mindsets, emotional health and relationships. "I'm excited by these deeper aspects of their lives that really speaks to the importance of these interventions beyond just reduction of depression," Davis said. RELATED STORIES —Psychedelics rapidly change the brain. Here's how. —Australia clears legal use of MDMA and psilocybin to treat PTSD and depression —'Magic mushroom' treatment for depression inches closer to approval Most of the patients shared that, following the original treatment, they'd engaged in self-reflection and therapy to help understand themselves and navigate life's challenges. Davis hypothesizes that the psychedelic experience catalyzes a deeper therapy process and would like to conduct future studies comparing the relative influences of psilocybin and psychotherapy in alleviating depression. "The biggest caveat of this study is the small sample size, and the fact that the original trial showed larger antidepressant effects than subsequent larger multi-site studies seem to be showing," Raison said. In a multi-site clinical trial with 233 participants, 37% of the 79 who received a single 25 mg dose of psilocybin, coupled with psychotherapy, went into remission from major depression. While these trials report less widespread antidepressant effects, they support the idea that psilocybin can effectively treat depression, Davis said, and he is keen to see how the findings of multi-site trials hold up five years post-treatment.
